[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343654-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343654-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ex-vivo-intestinal-organoid-models-current-state-of-the-art-and-challenges-in-disease-modelling-and-therapeutic-testing-for-colorectal-cancer","Ex Vivo Intestinal Organoid Models: Current State-of-the-Art and Challenges in Disease Modelling and Therapeutic Testing for Colorectal Cancer","","Despite improvements in participation in population-based screening programmes, colorectal cancer remains a major cause of cancer-related mortality worldwide. Targeted interventions are needed to reduce both health and economic burden. Traditional 2D monolayers of colorectal cancer cell lines are limited by reduced epithelial diversity, differentiation, mucus production, absent microbial interactions, and missing mechanical stresses. Advances have expanded to ex vivo patient-derived explants and tumour xenografts, plus organoid and microfluidic organ-on-a-chip cultures.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ex-vivo-intestinal-organoid-models-current-state-of-the-art-and-challenges-in-disease-modelling-and-therapeutic-testing-for-colorectal-cancer/343654/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ex-vivo-intestinal-organoid-models-current-state-of-the-art-and-challenges-in-disease-modelling-and-therapeutic-testing-for-colorectal-cancer/343654.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are colorectal cancer targeted interventions still needed despite screening programmes?","Question",{"text":63,"@type":64},"Colorectal cancer remains a major cause of cancer-related mortality worldwide, so targeted interventions are desirable to reduce health and economic burden.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What limitations of 2D colorectal cancer cell monolayers motivate newer model systems?",{"text":68,"@type":64},"They lack key complexity, including limited epithelial cell diversity and differentiation, reduced mucus production, missing microbial interactions, and absent mechanical stresses.",{"name":70,"@type":61,"acceptedAnswer":71},"How do organoid and microfluidic organ-on-a-chip cultures improve disease modelling and therapy testing?",{"text":72,"@type":64},"Organoid systems and organ-on-a-chip cultures add physiologically relevant complexity and can be used to model colorectal cancer and evaluate chemotherapeutic drug sensitivity and efficacy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343654,1790705643,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","cancers   \nReview  \nEx Vivo Intestinal Organoid Models: Current State-of-the-Art and Challenges in Disease Modelling and Therapeutic Testing for Colorectal Cancer  \nSarron Randall-Demllo 1, Ghanyah Al-Qadami 1, Anita E. Raposo 2, Chenkai Ma 2, Ilka K. Priebe 1, Maryam Hor 1, Rajvinder Singh 3 and Kim Y. C. Fung 2, *  \nCitation: Randall-Demllo, S.;  \nAl-Qadami, G.; Raposo, A.E.; Ma, C.; Priebe, I.K.; Hor, M.; Singh, R.; Fung, K.Y.C. Ex Vivo Intestinal Organoid Models: Current State-of-the-Art and Challenges in Disease Modelling and Therapeutic Testing for Colorectal Cancer. Cancers 2024, 16, 3664 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers16213664  \nAcademic Editor: Roberto Benelli  \nReceived: 20 September 2024  \nRevised: 24 October 2024  \nAccepted: 25 October 2024  \nPublished: 30 October 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Health and Biosecurity, Commonwealth Scientific and Industrial Research Organisation, Adelaide 5000, Australia; [sarron.randall-demllo@monash.edu](sarron.randall-demllo@monash.edu) (S.R.-D.); [ghanyah.al-qadami@csiro.au](ghanyah.al-qadami@csiro.au) (G.A.-Q.)  \n2 Health and Biosecurity, Commonwealth Scientific and Industrial Research Organisation, Westmead 2145, Australia; [anita.raposo@csiro.au](anita.raposo@csiro.au) (A.E.R.); [chenkai.ma@csiro.au](chenkai.ma@csiro.au) (C.M.)  \n3 Division of Gastroenterology, Lyell McEwin Hospital, Adelaide 5112, Australia  \n* Correspondence: [kim.fung@csiro.au](kim.fung@csiro.au)  \nSimple Summary: Colorectal cancer is one of the most commonly diagnosed cancers worldwide and is the second leading cause of cancer-related deaths. In the last decade, significant advances have been made in the development of cell-based models of disease, including for culturing and expanding cells derived from patient biopsy tissue. These advances have led to the development of intestinal organoids, 3D cellular models of the colon, that more accurately represent the disease state and hold the potential to improve our understanding of disease processes. Furthermore, increasing the complexity of these models to include important components, such as the gut microbiome and the stromal compartment with immune cells and vasculature, will provide deeper insight into individual drug responses and lead to better patient outcomes in the future.  \nAbstract: Despite improvements in participation in population-based screening programme, colorectal cancer remains a major cause of cancer-related mortality worldwide. Targeted interventions are desirable to reduce the health and economic burden of this disease. Two-dimensional monolayers of colorectal cancer cell lines represent the traditional in vitro models for disease and are often used for diverse purposes, including the delineation of molecular pathways associated with disease aetiology or the gauging of drug efficacy. The lack of complexity in such models, chiefly the limited epithelial cell diversity and differentiation, attenuated mucus production, lack of microbial interactions and mechanical stresses, has driven interest in the development of more holistic and physiologically relevant in vitro model systems. In particular, established ex vivo patient-derived explant and patientderived tumour xenograft models have been supplemented by progress in organoid and microfluidic organ-on-a-chip cultures. Here, we discuss the applicability of advanced culturing technologies, such as organoid systems, as models for colorectal cancer and for testing chemotherapeutic drug sensitivity and efficacy. We highlight current challenges associated with organoid technologies and discuss their futur","cbCaij9ioLo6k9ks","https://ap.wps.com/l/cbCaij9ioLo6k9ks","pdf",730614,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction\n## Colorectal cancer burden and screening impact\n## Limitations of traditional in vitro models\n## Growth of advanced therapies and biomarker constraints","[{\"question\":\"Why are colorectal cancer targeted interventions still needed despite screening programmes?\",\"answer\":\"Colorectal cancer remains a major cause of cancer-related mortality worldwide, so targeted interventions are desirable to reduce health and economic burden.\"},{\"question\":\"What limitations of 2D colorectal cancer cell monolayers motivate newer model systems?\",\"answer\":\"They lack key complexity, including limited epithelial cell diversity and differentiation, reduced mucus production, missing microbial interactions, and absent mechanical stresses.\"},{\"question\":\"How do organoid and microfluidic organ-on-a-chip cultures improve disease modelling and therapy testing?\",\"answer\":\"Organoid systems and organ-on-a-chip cultures add physiologically relevant complexity and can be used to model colorectal cancer and evaluate chemotherapeutic drug sensitivity and efficacy.\"}]","Ex Vivo Intestinal Organoid Models: Current State-of-the-Art and Challenges in Disease Modelling and Therapeutic Testing for Colorectal Cancer | PDF",1790051693,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f6b294259bf068aa846b5bd2f9978ac.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55e13c7088ff2beeaf483d2b343d3254.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fecd1510b1b1a84f9208aa4a0240185.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/506af4f60a2b7a2a9ffe53bfc97c315c.webp",980,692]